IPSYLON: Observational Study Evaluating the Psychic Impact of the Diagnostic Announcement and Care for Children Treated for Cancer

Sponsor
Centre Leon Berard (Other)
Overall Status
Terminated
CT.gov ID
NCT04244955
Collaborator
(none)
5
1
20.2
0.2

Study Details

Study Description

Brief Summary

The cancer diagnostic announcement and cancer care are both physical and psychological highlights. The main objective is to analyze significant psychological difficulties in children aged 6 to 16 treated for cancer.

Condition or Disease Intervention/Treatment Phase
  • Other: Semi-directive interviews

Detailed Description

Symptoms of post traumatic stress disorder in young children are often underdiagnosed because the criteria of DSM-IV and ICD-10 are not suitable for these children. These symptoms are nightmares, sleep problems, compulsive and joyless gambling, regression, hyper attention, anxiety over new separation, and new fears. It is also known that the disorders are readily more marked at the start of treatment and then subside throughout the first year. Some may appear afterwards after treatment.

To our knowledge, no study has evaluated the prevalence of mental disorders linked to diagnosis and care during treatment and their link with the practice of care. This study will focus on disorders during treatment. We will study the psychic impact of the announcement of diagnosis and care, whether they belong to the traumatic dimension or not. For this, we will use the validated French version of the Child Post-Traumatic Stress Reaction Index (CPTS-RI) scale. It is the most widely used scale in clinical research of trauma and reactive mental disorders in children 6 to 16 years of age. We will also assess the most disturbing elements for the child and the main clinical manifestations found in order to improve the detection of mental disorders and the care support for these children.

This research will allow us to assess the prevalence of mental disorders in connection with the care practiced within the Institute of Pediatric Hematology and Oncology (IHOPe) and, subsequently, to establish a another intervention research protocol to improve our practices and the care of these patients.

Study Design

Study Type:
Observational
Actual Enrollment :
5 participants
Observational Model:
Other
Time Perspective:
Cross-Sectional
Official Title:
Observational Study Evaluating the Psychic Impact of the Diagnostic Announcement and Care for Children Treated for Cancer
Actual Study Start Date :
Jan 22, 2020
Actual Primary Completion Date :
Sep 29, 2021
Actual Study Completion Date :
Sep 29, 2021

Outcome Measures

Primary Outcome Measures

  1. Analyze of significant psychological difficulties in children aged 6 to 16 [30 minutes]

    Score at the Child Post-Traumatic Stress Reaction Index (CPTS-RI) questionnaire. A score strictly greater than 24 on the CPTS-RI questionnaire will be considered clinically significant for the primary endpoint

Secondary Outcome Measures

  1. Evaluation of the most disturbing elements for the child and the main clinical manifestations found. [30 minutes]

    Most disturbing elements for the child (since the start of care and in invasive and / or repeated care) and the main clinical manifestations found during the semi-directive interviews, carried out by the child psychiatrist.

  2. Collection of the opinion of the caregivers (doctors, nurses) of each patient on the psychic impact of care on the child. [30 minutes]

    Rating of the level of difficulty similar to the CPTS-RI scale: none, mild, moderate, severe or very severe.

  3. Evaluation of the agreement between the levels of difficulty rated by the child and his caregivers. [30 minutes]

    Measure of agreement between the two evaluations using Kappa coefficient

Eligibility Criteria

Criteria

Ages Eligible for Study:
6 Years to 16 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patient aged 6 to 16 years;

  • Patient diagnosed for a malignant pathology for at least one month and maximum 2 months;

  • Patient treated at the IHOPe;

  • Non-opposition of the parents and the child under study.

Exclusion Criteria:
  • Difficulty speaking and understanding French;

  • Patient who is not able to express himself because the somatic medical conditions do not allow a verbal exchange.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Centre Léon Bérard Lyon France 69008

Sponsors and Collaborators

  • Centre Leon Berard

Investigators

  • Principal Investigator: Elodie SAVOURÉ, M.D, Centre Leon Berard

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Centre Leon Berard
ClinicalTrials.gov Identifier:
NCT04244955
Other Study ID Numbers:
  • ET19-292 IPSYLON
First Posted:
Jan 28, 2020
Last Update Posted:
Oct 13, 2021
Last Verified:
Oct 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Oct 13, 2021